PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Anti-TdT-APC, human and mouse
CD101-APC, mouse
CD105-PE-Vio770, mouse
CD140b-APC, mouse
CD141 (BDCA-3) antibodies, human
CD146 (LSEC)-PerCP-Vio700, mouse
CD161 pure, human
CD164-APC, human
CD164-PE, human
CD180 (RP105)-FITC, human
CD181 (CXCR1)-APC-Vio770, human
CD201 (EPCR)-FITC, human
CD209 (DC-SIGN)-FITC, human
CD218 (IL-18Rα)-APC, human
CD240DCE-APC, human
CD36-PerCP-Vio700, human